Agilent Technologies, Inc. (NYSE:A) Shares Purchased by Exchange Traded Concepts LLC

Exchange Traded Concepts LLC increased its position in shares of Agilent Technologies, Inc. (NYSE:A) by 6.8% in the first quarter, HoldingsChannel.com reports. The firm owned 10,941 shares of the medical research company’s stock after acquiring an additional 701 shares during the quarter. Exchange Traded Concepts LLC’s holdings in Agilent Technologies were worth $1,280,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. Redwood Park Advisors LLC purchased a new stake in shares of Agilent Technologies in the fourth quarter valued at about $27,000. Lee Danner & Bass Inc. purchased a new position in Agilent Technologies in the fourth quarter valued at about $29,000. Whipplewood Advisors LLC increased its holdings in Agilent Technologies by 286.2% in the first quarter. Whipplewood Advisors LLC now owns 251 shares of the medical research company’s stock valued at $29,000 after buying an additional 186 shares in the last quarter. Sunbelt Securities Inc. grew its position in shares of Agilent Technologies by 640.0% in the fourth quarter. Sunbelt Securities Inc. now owns 222 shares of the medical research company’s stock valued at $30,000 after purchasing an additional 192 shares during the last quarter. Finally, Opal Wealth Advisors LLC acquired a new stake in shares of Agilent Technologies in the first quarter valued at approximately $31,000. Institutional investors and hedge funds own 87.42% of the company’s stock.

Agilent Technologies Trading Down 0.4%

A opened at $115.62 on Thursday. The company has a current ratio of 2.09, a quick ratio of 1.60 and a debt-to-equity ratio of 0.55. The stock has a market capitalization of $32.84 billion, a PE ratio of 28.55, a PEG ratio of 3.52 and a beta of 1.23. Agilent Technologies, Inc. has a 1-year low of $96.43 and a 1-year high of $153.84. The firm has a 50-day moving average price of $110.10 and a two-hundred day moving average price of $125.03.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, May 28th. The medical research company reported $1.31 EPS for the quarter, topping the consensus estimate of $1.26 by $0.05. Agilent Technologies had a net margin of 17.59% and a return on equity of 25.92%. The company had revenue of $1.67 billion during the quarter, compared to analysts’ expectations of $1.63 billion. During the same quarter in the previous year, the company earned $1.22 EPS. Agilent Technologies’s revenue was up 6.0% on a year-over-year basis. As a group, equities analysts anticipate that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 23rd. Stockholders of record on Tuesday, July 1st will be issued a $0.248 dividend. This represents a $0.99 annualized dividend and a dividend yield of 0.86%. The ex-dividend date is Tuesday, July 1st. Agilent Technologies’s dividend payout ratio (DPR) is presently 24.44%.

Insider Activity

In other Agilent Technologies news, Director Daniel K. Podolsky sold 1,819 shares of the company’s stock in a transaction on Monday, March 31st. The shares were sold at an average price of $116.46, for a total transaction of $211,840.74. Following the sale, the director now directly owns 35,737 shares of the company’s stock, valued at approximately $4,161,931.02. This represents a 4.84% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Corporate insiders own 0.26% of the company’s stock.

Analysts Set New Price Targets

A number of analysts recently issued reports on A shares. UBS Group decreased their target price on shares of Agilent Technologies from $150.00 to $130.00 and set a “neutral” rating on the stock in a research report on Thursday, May 29th. Leerink Partners lifted their price target on shares of Agilent Technologies to $135.00 and gave the stock a “buy” rating in a research note on Friday, May 30th. TD Cowen raised their price objective on shares of Agilent Technologies to $150.00 and gave the stock a “buy” rating in a report on Thursday, May 29th. Robert W. Baird decreased their price target on shares of Agilent Technologies from $159.00 to $140.00 and set an “outperform” rating for the company in a report on Thursday, May 22nd. Finally, Wall Street Zen lowered shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, June 14th. Eight investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $140.15.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.